title: Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries-Polish pilot group.
abstract: OBJECTIVE
  The article presents the results of treatment with vascular brachytherapy (VBT) in superficial femoral arteries. This method aims to minimize frequency of restenosis after percutaneous transluminal angioplasty (PTA).
  
  
  METHODS
  Treatment was carried out in 20 cases. The patients with severe stenoses or total occlusions verified in angiography were selected. In the group of 19 patients, two were women (the average age of the patients was 58.7 years). VBT was performed immediately after PTA. A 15-Gy dose, with high dose rate, was applied. The dose was calculated based on individually chosen distance from the internal surface of the artery wall, which varied from 2 to 3 mm. The mean observation time after treatment was 8 months. The shortest time was 1 month and the longest 14 months. At the end of the observation time, the control DSA angiography was performed on every patient.
  
  
  RESULTS
  During the first 2 months, in three cases, an acute thrombosis in treated artery was observed. In the third month, one treated artery occluded. In the sixth month of observation, one case of acute thrombosis was observed. The rest of the patients were free of restenoses.
  
  
  CONCLUSIONS
  (1) In superficial femoral arteries, a low value of ankle brachial pressure index (ABPI; below 0.4) is very probably responsible for acute thrombosis after PTA with or without stent implantation followed by VBT. (2) Diabetes, rest ischaemia before treatment, poor vessel status confirmed in angiography may also be responsible for acute thrombosis after VBT. (3) Anticoagulants or antiplatelet (ticlipidine) treatment must be ordered for 6 months after VBT in patients with implanted stents.
authors.affiliation: Center of Oncology, Institute, Al. Armii Krajowej 15, 44-101, Gliwice, Poland. piotrw@io.gliwice.pl
authors.forename: Piotr
authors.initials: P
authors.lastname: Walichiewicz
authors.forename: Jerzy
authors.initials: J
authors.lastname: Piecuch
authors.forename: Brygida
authors.initials: B
authors.lastname: Bialas
authors.forename: Witold
authors.initials: W
authors.lastname: Orkisz
authors.forename: Marek
authors.initials: M
authors.lastname: Fijalkowski
authors.forename: Leszek
authors.initials: L
authors.lastname: Miszczyk
mesh_terms: D000368:Aged; D000800:Angioplasty, Balloon; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D019917:Blood Vessel Prosthesis Implantation; D001918:Brachytherapy; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging / Q000601:surgery*; D005720:Gamma Rays / Q000627:therapeutic use; D006083:Graft Occlusion, Vascular / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011044:Poland; D011859:Radiography; D012086:Reoperation; D012307:Risk Factors; D015607:Stents; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D016909:Tibial Arteries / Q000000981:diagnostic imaging / Q000601:surgery; D016896:Treatment Outcome